CDC16 | Cell division cycle 16 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDC25A | Cell division cycle 25A | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDC25B | Cell division cycle 25B | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CDC34 | Cell division cycle 34 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CDC37 | Cell division cycle 37 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CDC6 | Cell division cycle 6 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH5 | Cadherin 5, type 2 (vascular endothelium) | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDK1 | Cyclin-dependent kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK2 | Cyclin-dependent kinase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CDK6 | Cyclin-dependent kinase 6 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CDK7 | Cyclin-dependent kinase 7 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CFHR1 | Complement factor H-related 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFLAR | CASP8 and FADD-like apoptosis regulator | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CGA | Glycoprotein hormones, alpha polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB | Chorionic gonadotropin, beta polypeptide | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB5 | Chorionic gonadotropin, beta polypeptide 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CHD7 | Chromodomain helicase DNA binding protein 7 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CHEK1 | Checkpoint kinase 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
CHEK2 | Checkpoint kinase 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Group enriched |
CIB2 | Calcium and integrin binding family member 2 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CKS1B | CDC28 protein kinase regulatory subunit 1B | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CKS2 | CDC28 protein kinase regulatory subunit 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLEC3B | C-type lectin domain family 3, member B | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CLIP1 | CAP-GLY domain containing linker protein 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CLSTN1 | Calsyntenin 1 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CLU | Clusterin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CNN1 | Calponin 1, basic, smooth muscle | Cancer-related genes Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CNTF | Ciliary neurotrophic factor | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
COL11A1 | Collagen, type XI, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL17A1 | Collagen, type XVII, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |